Ken Robbins

478 total citations
8 papers, 371 citations indexed

About

Ken Robbins is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, Ken Robbins has authored 8 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Ken Robbins's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Ken Robbins is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Ken Robbins collaborates with scholars based in United States, Czechia and Serbia. Ken Robbins's co-authors include Robert C.G. Martin, Dana Tomalty, Cliff Tatum, Miloslav Roček, Radek Pádr, Ryan O’Hara, Petar Bošnjaković, Matthew Bower, Tomáš Andrašina and Ricardo García Mónaco and has published in prestigious journals such as Annals of Surgical Oncology, Breast Cancer Research and Treatment and HPB.

In The Last Decade

Ken Robbins

8 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Robbins United States	6	332	257	137	133	34	8	371
Dana Tomalty United States	7	398 1.2×	301 1.2×	153 1.1×	173 1.3×	40 1.2×	9	438
Luca Mulazzani Italy	7	315 0.9×	238 0.9×	131 1.0×	169 1.3×	33 1.0×	12	397
Paolo Coschiera Italy	5	287 0.9×	208 0.8×	105 0.8×	136 1.0×	32 0.9×	7	331
Julien Leporrier France	3	326 1.0×	331 1.3×	98 0.7×	181 1.4×	35 1.0×	3	439
Wendy Langeberg United States	2	318 1.0×	354 1.4×	114 0.8×	172 1.3×	69 2.0×	3	496
P Ségol France	4	247 0.7×	275 1.1×	110 0.8×	150 1.1×	36 1.1×	11	391
Julie N. Leal United States	9	276 0.8×	287 1.1×	102 0.7×	214 1.6×	37 1.1×	14	424
Jaarke Vannoote Belgium	7	228 0.7×	203 0.8×	146 1.1×	94 0.7×	66 1.9×	12	335
Giuseppe Cardaci Australia	4	266 0.8×	145 0.6×	158 1.2×	103 0.8×	125 3.7×	13	353
C B Wood United Kingdom	5	224 0.7×	204 0.8×	73 0.5×	127 1.0×	23 0.7×	6	324

Countries citing papers authored by Ken Robbins

Since Specialization

Citations

This map shows the geographic impact of Ken Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Robbins more than expected).

Fields of papers citing papers by Ken Robbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Robbins. The network helps show where Ken Robbins may publish in the future.

Co-authorship network of co-authors of Ken Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Robbins. A scholar is included among the top collaborators of Ken Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Robbins. Ken Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tatum, Cliff, et al.. (2012). Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Pancreatic Carcinoma to the Liver: A Multi-Institutional Registry. Journal of Oncology. 2012. 1–6. 10 indexed citations

2.

Fouad, Heba, et al.. (2012). Hepatic Arterial Therapy with Drug-Eluting Beads in the Management of Metastatic Bronchogenic Carcinoma to the Liver: A Multi-Institutional Registry. Journal of Oncology. 2012. 1–6. 1 indexed citations

3.

Martin, Robert C.G., et al.. (2011). Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin. Breast Cancer Research and Treatment. 132(2). 753–763. 26 indexed citations

4.

Bower, Matthew, Ken Robbins, Dana Tomalty, et al.. (2010). Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB. 12(1). 31–36. 37 indexed citations

5.

Martin, Robert C.G., Ken Robbins, Dana Tomalty, et al.. (2010). Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study. Annals of Surgical Oncology. 18(1). 192–198. 151 indexed citations

6.

Martin, Robert C.G., Ken Robbins, Dana Tomalty, et al.. (2009). Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World Journal of Surgical Oncology. 7(1). 80–80. 80 indexed citations

7.

Martin, Robert C.G., et al.. (2009). Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. Journal of Oncology. 2009. 1–6. 65 indexed citations

8.

Robbins, Ken. (1984). Building a house. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact